REFERENCES
- Pedersen RC, Brownie AC. The mechanisms of action of adrenocorticotrophic hormone on cholesterol metabolism in the adrenal cortex. In: Litwack G, editor. Biochemical actions of hor-mones, vol 21. New York, NY: Academic Press, 1986: 129–66.
- Berg AL, Nilsson-Ehle P. Direct effects of ACTH on plasma lipoprotein metabolism in man: Studies in vivo and in vitro. Metabolism 1994; 43: 90–7.
- Berg AL, Nilsson-Ehle P. ACTH lowers serum lipids in steroid treated hyperlipidemic patients with kidney disease. Kidney Int 1996; 50: 538–42.
- Arnadottir M, Berg AL, Dallongeville J, Fruchart JC, Nilsson-Ehle P. Adrenocorticotrophic hormone lowers serum Lp (a) and LDL cholesterol concentrations but does not influence triglyceride metabolism in hemodialysis patients. Kidney Int 1997; 52: 1651–5.
- Arnadottir M, Berg AL, Kronenberg F, Lingenhel A, Hugosson T, Hegbrant J, Nilsson-Ehle P. Corticotropin-induced reduction of plasma lipoprotein (a) concentrations in healthy individuals and hemodialysis patients: relation to apolipo-protein(a) size polymorphism. Metabolism 1999; 48: 342–6.
- Bartens W, Kramer-Guth A, Wanner C. Corticotropin increases the receptor-specific uptake of native low-density lipoprotein (LDL)- but not oxidized LDL and native or oxidized lip oprotein (a) (Lp[a])- in HEPG2 cells: No evidence for Lp(a) catabolism via the LDL receptor. Metabolism 1997; 46: 726–9.
- Mahley RW. Apolipoprotein E: cholesterol trans-port protein with expanding role in cell biology. Science 1988; 240: 622–30.
- Prack MM, Nicosia M, Williams DL, Gwynne J. Relationship between apolipoprotein E mRNA expression and tissue cholesterol content in rat adrenal gland. J Lipid Res 1991; 32: 1611–8.
- Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499–502.
- Parsy D, Clayey V, Fievet C, Kora I, Duriez P, Fruchart JC. Quantification of apolipoprotein C-III in serum by a noncompetitive immunoenzym-°metric assay. Clin Chem 1985; 31:1632–5
- Alaupovic P. Apolipoprotein composition as the basis for classifying plasma lipoproteins. Characterization of apo A and apo B-containing lipoprotein families. Prog Lipid Res 1991; 30: 105–38.
- Yamada N, Shames DN, Stoudmire JB, Havel RJ. Metabolism of lipoproteins containing apolipoprotein B-100 in blood plasma of rabbits: heterogeneity related to the presence of apolipo-protein E. Proc Natl Acad Sci USA 1987; 83: 3479–83.
- Ji ZS, Fazio S, Lee YL, Mahley RW. Secretion-capture role for apolipoprotein E in remnant lipo-protein metabolism involving cell surface heparan sulfate proteoglycan. J Biol Chem 1994; 269: 2764–72.
- Ishibashi S, Herz J, Maeda N, Goldstein JL, Brown MS. The two-receptor model of lipoprotein clearance: tests of the hypothesis in "knockout" mice lacking the low density lipoprotein receptor, apolipoprotein E, or both proteins. Proc Natl Acad Sci USA 1994; 91: 4431–5.
- Yamada N, Shimano H, Mokuno H, Ishibashi S, Gotoda T, Kawakami K, Watanabe Y, Akanuma Y, Murase T, Takaku F. Increased clearance of plasma cholesterol after injection of apolipoprotein E into Watanable heritable hyperli-pidemic rabbits. Proc Natl Acad Sci USA 1989; 86: 665–9.
- Mahley RW, Weisgraber KH, Hussain MM, Greenman B, Fisher M, Vogel T, Gorecki M. Intravenous infusion of apolipoprotein E acceler-ates clearance of plasma lipoproteins in rabbits. J Clin Invest 1989; 83: 2125–30.
- Shimano H, Yamada N, Katzuki M, Shimada M, Gotoda T, Harada K, Murase T, Fukazawa F, Takaku F, Yazaki Y. Overexpression of apolipo-protein E in transgenic mice: a marked reduction in plasma lipoproteins except high density lipo-protein, and resistance against diet-induced hyper-cholesterolemia. Proc Natl Acad Sci USA 1992; 89: 1750–4.
- Osuga J, Yonemoto M, Yamada N, Shimano H, Yagyu H, Ohashi K, Harada K, Kamei T, Yazaki Y, Ishibashi S. Cholesterol lowering in low density lipoprotein receptor knockout mice overex-pressing apolipoprotein E. J Clin Invest 1998; 102: 386–94.
- Arnadottir M, Dallongeville J, Fruchart JC, Thysell H, Nilsson-Ehle P. Evidence that reduced lipoprotein lipase activity is not a primary patho-genetic factor for hypertriglyceridemia in renal failure. Kidney Int 1995; 48: 779–84.